Skye bioscience inc

GAINERS: Craftport Cannabis (OTC:BHHKF) shares closed up 580.00% at $0.00

GAINERS: Tetra Bio Pharma (OTC:TBPMF) shares closed up 52.50% at $0.01

Skye Bioscience, Inc. (OTCQB: SKYE), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma and ocular hypertension, announced that its contract manufacturer, NextPharma Oy, in Finland, has completed production of placebo and

On Tuesday, shares of Skye Bioscience (OTC: SKYE) experienced volatile short activity. After the activity, the stock price went up +3.03% to $0.017. The overall sentiment for SKYE has been Bullish.

Skye Bioscience, Inc.

SOL Global Investments Corp. (OTCQB: SKYE) (CSE:SOL) (FSE:9SB) announced that it is up to date on all interest payments and has repaid an additional $1.0 million towards its $50 million credit facility with an arm's length lender, reducing the principal amount of the credit facility to $

Skye Bioscience, Inc. (OTCQB: SKYE), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, has received a positive recommendation following a pre-specified data review by the safety review committee ("SRC") based on dosing of the sec

Skye Bioscience, Inc. (OTCQB: SKYE) a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, reported that its phase 2 clinical trial protocol has received study level approval from a central institutional review board

MJBiz CEO To Step Down Marijuana Business Daily's Chris Walsh will step down as CEO in January.